1Weinblatt ME,Kremer JM,Bankhurst A,et al.A trial of etanercept:a recombinant tumor necrosis factor receptor:Fc fusion protein in patients with rheumatoid arthritis receiving methotrexate. New Engl J Med, 1999,340:253-259.
2Lovell Dj,Giannini EH,Reiff A ,et al. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter,open-label,extended-treatment trial.Arthritis Rheum,2003,48:
6Carlson E,Rothfield N.Etanercept-induced lupus likesyndrome in a patient with rheumatoid arthritis. Arthritis Rheum,2003,48:1165-1166.
7Brown SL,Greene MH,Gershon SK,et al.Tumor necrosis factor antagonist therapy and lymphoma development:twenty-six cases reported to the Food and Drug Administration.Arthritis Rheum,2002,46:3151-3158.
9Moreland LW,Baumgartner SW,Schiff MH,et al.Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. New Eng J Med,1997,337:141-147.
10Moreland LW,Cohen SB,Baumgartner SW,et al. Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.J Rheumatol,2001,28:1238-1244.
